Laure Marignol, Professor in Radiation Biology in Trinity College Dublin, shared a post on LinkedIn:
“SBRT is an exciting option for localized kidney cancer. By integrating sex as a biological variable (SABV) into research and outcome reporting, we can build evidence that is not only stronger but also more equitable – helping ensure treatment advances benefit everyone. Check out our paper here, another example of student work from the Discipline of Radiation Therapy TCD.”
Title: Biological sex representation and reporting in stereotactic body radiotherapy for kidney cancer: A review of clinical studies
Authors: Sylvia Nwokolo, Laure Marignol
Read the Full Article at Science Direct.
More posts featuring SBRT on OncoDaily.